Log In
Print
BCIQ
Print
Print this Print this
 

Enadenotucirev (formerly ColoAd1)

  Manage Alerts
Collapse Summary General Information
Company PsiOxus Therapeutics Ltd.
DescriptionOncolytic Ad11/Ad3 chimeric group B adenovirus
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today